Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 17

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Exploring the Therapeutic Potential of Medicinal Plants in the Context of Gastrointestinal Health: A Review

Julián-Flores, Antonio, Aguilar-Zárate, Pedro, Michel, Mariela R., Sepúlveda-Torre, Leonardo, Torres-León, Cristian, Aguilar, Cristóbal N., Chávez-González, Mónica L.·2025·Plants

Abstract

Medicinal plants represent promising sources for the treatment of gastrointestinal disorders because of their abundance in bioactive compounds with therapeutic properties. Throughout history, various plant species have been used to alleviate digestive ailments, and studies have revealed the presence of metabolites with anti-inflammatory, antibacterial, antiviral, antiparasitic, antidiarrheal, antioxidant, and anticancer activities. The secondary metabolites responsible for these properties include alkaloids, terpenoids, and phenolic compounds, with the latter, particularly flavonoids, being the most associated with their bioactivities. Gastrointestinal diseases, such as gastritis, peptic ulcers, gastroesophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome, and gastrointestinal cancer, are caused primarily by bacteria, parasites, viruses, and the consumption of raw or undercooked foods. These conditions significantly impact human health, necessitating the development of safer and more effective therapeutic alternatives. After an extensive literature review, several plant species with widespread use in the treatment of these disorders were identified, including Matricaria chamomilla, Mentha spicata, Melissa officinalis, Artemisia ludoviciana, Flourensia cernua, Phoradendron californicum, and Turnera difusa. This study revealed that the analyzed plants are rich in bioactive compounds, which confer their medicinal properties. However, many other plants commonly used to treat digestive disorders have been scarcely studied, highlighting the need for further research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/plants14050642

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 105

  1. Leader, 2020, Relationship between parent-reported gastrointestinal symptoms, sleep problems, autism spectrum disorder symptoms, and behavior problems in children and adolescents with 22q11.2 deletion syndrome, Res. Dev. Disabil., 104, 103698, 10.1016/j.ridd.2020.103698 · DOI
  2. Kang, D.W., Adams, J.B., Gregory, A.C., Borody, T., Chittick, L., Fasano, A., Khoruts, A., Geis, E., Maldonado, J., and McDonough-Means, S. (2017). Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: An open-label study. Microbiome, 5. · DOI · Paper page
  3. Liu, 2022, Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives, Aging Dis., 13, 1106, 10.14336/AD.2022.0104 · DOI · Paper page
  4. Mazzocchi, 2023, Plant-based diets in gastrointestinal diseases: Which evidence?, Best Pract. Res. Clin. Gastroenterol., 62–63, 101829, 10.1016/j.bpg.2023.101829 · DOI
  5. So, 2021, Plant-based diets in gastrointestinal disorders: Something, nothing, or everything?, Lancet Gastroenterol. Hepatol., 6, 992, 10.1016/S2468-1253(21)00380-0 · DOI
  6. Sharma, 2017, Antibacterial activities of medicinal plants used in Mexican traditional medicine, J. Ethnopharmacol., 208, 264, 10.1016/j.jep.2016.04.045 · DOI
  7. Sellami, 2018, Herbal medicine for sports: A review, J. Int. Soc. Sports Nutr., 15, 14, 10.1186/s12970-018-0218-y · DOI
  8. Atanasov, 2015, Discovery and resupply of pharmacologically active plant-derived natural products: A review, Biotechnol Adv., 33, 1582, 10.1016/j.biotechadv.2015.08.001 · DOI
  9. Guldiken, 2018, Phytochemicals of herbs and spices: Health versus toxicological effects, Food Chem. Toxicol., 119, 37, 10.1016/j.fct.2018.05.050 · DOI
  10. Feng, 2020, Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs, Theranostics, 10, 11278, 10.7150/thno.47289 · DOI
  11. 2021, Prevalencia e impacto de resistencias a antimicrobianos en infecciones gastrointestinales: Una revisión, Rev. Gastroenterol. Mex., 86, 265
  12. Sensoy, 2021, A review on the food digestion in the digestive tract and the used in vitro models, Curr. Res. Food Sci., 4, 308, 10.1016/j.crfs.2021.04.004 · DOI
  13. Ebrahimi, 2021, Polyphenols: A Comprehensive Review of their Nutritional Properties, Open Biotechnol. J., 15, 164, 10.2174/1874070702115010164 · DOI
  14. Wang, R., Li, Z., Liu, S., and Zhang, D. (2023). Global, regional, and national burden of 10 digestive diseases in 204 countries and territories from 1990 to 2019. Front. Public Health, 11. · DOI
  15. Peery, 2022, Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021, Gastroenterology, 162, 621, 10.1053/j.gastro.2021.10.017 · DOI · Paper page
  16. Yang, 2022, Immunological Perspective: Helicobacter pylori Infection and Gastritis, Mediators Inflamm., 2022, 2944156, 10.1155/2022/2944156 · DOI
  17. Li, 2020, Association of Symptoms with Eating Habits and Food Preferences in Chronic Gastritis Patients: A Cross-Sectional Study, Evid.-Based Complement. Altern. Med., 2020, 5197201, 10.1155/2020/5197201 · DOI
  18. Wu, 2021, GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression, Nat. Commun., 12, 1146, 10.1038/s41467-021-21280-7 · DOI
  19. Serafim, C., Araruna, M.E., Alves Júnior, E., Diniz, M., Hiruma-Lima, C., and Batista, L. (2020). A Review of the Role of Flavonoids in Peptic Ulcer (2010–2020). Molecules, 25. · DOI
  20. Katz, 2022, ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease, Am. J. Gastroenterol., 117, 27, 10.14309/ajg.0000000000001538 · DOI · Paper page
  21. Delshad, 2019, Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms, Gastroenterology, 158, 1250, 10.1053/j.gastro.2019.12.014 · DOI
  22. Chong, P.P., Chin, V.K., Looi, C.Y., Wong, W.F., Madhavan, P., and Yong, V.C. (2019). The microbiome and irritable bowel syndrome—A review on the pathophysiology, current research and future therapy. Front. Microbiol., 10. · DOI
  23. Pimentel, 2020, Microbiome and Its Role in Irritable Bowel Syndrome, Dig. Dis. Sci., 65, 829, 10.1007/s10620-020-06109-5 · DOI
  24. Stojanov, S., Berlec, A., and Štrukelj, B. (2020). The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease. Microorganisms, 8. · DOI · Paper page
  25. Guan, 2019, Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease, J. Immunol. Res., 2019, 7247238, 10.1155/2019/7247238 · DOI
  26. Ağagündüz, D., Cocozza, E., Cemali, Ö., Bayazıt, A.D., Nanì, M.F., Cerqua, I., Morgillo, F., Saygılı, S.K., Berni Canani, R., and Amero, P. (2023). Understanding the role of the gut microbiome in gastrointestinal cancer: A review. Front. Pharmacol., 14. · DOI · Paper page
  27. Waldum, H., and Fossmark, R. (2021). Gastritis, Gastric Polyps and Gastric Cancer. Int. J. Mol. Sci., 22. · DOI
  28. Sung, 2021, Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660 · DOI · Paper page
  29. Paone, 2020, Mucus barrier, mucins and gut microbiota: The expected slimy partners?, Gut, 69, 2232, 10.1136/gutjnl-2020-322260 · DOI
  30. Thursby, 2017, Introduction to the human gut microbiota, Biochem. J., 474, 1823, 10.1042/BCJ20160510 · DOI · Paper page
  31. Rinninella, E., Raoul, P., Cintoni, M., Franceschi, F., Miggiano, G.A.D., Gasbarrini, A., and Mele, M.C. (2019). What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases. Microorganisms, 7. · DOI · Paper page
  32. Wallig, M.A., Bolon, B., Haschek, W.M., and Rousseaux, C.G. (2018). Digestive System. Fundamentals of Toxicologic Pathology, Academic Press. [3rd ed.]. · DOI
  33. Mirzaei, R., Dehkhodaie, E., Bouzari, B., Rahimi, M., Gholestani, A., Hosseini-Fard, S.R., Keyvani, H., Teimoori, A., and Karampoor, S. (2022). Dual role of microbiota-derived short-chain fatty acids on host and pathogen. Biomed. Pharmacother., 145. · DOI
  34. Sasso, 2023, Gut Microbiome-Brain Alliance: A Landscape View into Mental and Gastrointestinal Health and Disorders, ACS Chem. Neurosci., 14, 1717, 10.1021/acschemneuro.3c00127 · DOI
  35. Durack, 2018, The gut microbiome: Relationships with disease and opportunities for therapy, J. Exp. Med., 216, 20, 10.1084/jem.20180448 · DOI
  36. Katzung, B.G. (2017). Basic and Clinical Pharmacology, McGraw-Hill Education. [14th ed.].
  37. Lorigooini, 2018, Medicinal plants: Past history and future perspective, J. Herbmed Pharmaco., 7, 1, 10.15171/jhp.2018.01 · DOI
  38. Prinsloo, 2018, Medicinal plant harvesting, sustainability and cultivation in South Africa, Biol. Conserv., 227, 335, 10.1016/j.biocon.2018.09.018 · DOI
  39. He, 2018, Crossing the roof of the world: Trade in medicinal plants from Nepal to China, J. Ethnopharmacol., 224, 100, 10.1016/j.jep.2018.04.034 · DOI
  40. Akhtar, 2018, Medicinal plants as a potential source of chemopreventive agents, Anticancer Plants: Natural Products and Biotechnological Implements, Volume 2, 109
  41. Aguilar, 2023, Medicinal plants used by rural communities in the arid zone of Viesca and Parras Coahuila in northeast Mexico, Saudi Pharm. J., 31, 21, 10.1016/j.jsps.2022.11.003 · DOI
  42. Spina, D., Barbieri, C., Carbone, R., Hamam, M., D’Amico, M., and Di Vita, G. (2023). Market Trends of Medicinal and Aromatic Plants in Italy: Future Scenarios Based on the Delphi Method. Agronomy, 13. · DOI
  43. Oguntibeju, 2018, Medicinal plants with anti-inflammatory activities from selected countries and regions of Africa, J. Inflamm. Res., 11, 307, 10.2147/JIR.S167789 · DOI
  44. Mata, 2019, Chemistry and Biology of Selected Mexican Medicinal Plants, Prog. Chem. Org. Nat. Prod., 108, 1
  45. Gould, 2023, Transmission of yellow fever vaccine virus through blood transfusion and organ transplantation in the USA in 2021: Report of an investigation, Lancet Microbe, 4, e711, 10.1016/S2666-5247(23)00170-2 · DOI
  46. Ogunyemi, 2019, Biosynthesis and characterization of magnesium oxide and manganese dioxide nanoparticles using Matricaria chamomilla L. extract and its inhibitory effect on Acidovorax oryzae strain RS-2, Artif. Cells Nanomed. Biotechnol., 47, 2230, 10.1080/21691401.2019.1622552 · DOI
  47. Akram, 2024, An updated comprehensive review of the therapeutic properties of Chamomile (Matricaria chamomilla L.), Int. J. Food Prop., 27, 133, 10.1080/10942912.2023.2293661 · DOI
  48. Borjac, 2022, Matricaria chamomilla: A valuable insight into recent advances in medicinal uses and pharmacological activities, Phytochem. Rev., 21, 1913, 10.1007/s11101-022-09817-0 · DOI
  49. El Mihyaoui, A., Esteves da Silva, J.C.G., Charfi, S., Candela Castillo, M.E., Lamarti, A., and Arnao, M.B. (2022). Chamomile (Matricaria chamomilla L.): A Review of Ethnomedicinal Use, Phytochemistry and Pharmacological Uses. Life, 12. · DOI
  50. Chrysargyris, 2019, The combined and single effect of salinity and copper stress on growth and quality of Mentha spicata plants, J. Hazard. Mater., 368, 584, 10.1016/j.jhazmat.2019.01.058 · DOI
  51. Mahboubi, 2021, Mentha spicata L. essential oil, phytochemistry and its effectiveness in flatulence, J. Tradit. Med. Complement., 11, 75, 10.1016/j.jtcme.2017.08.011 · DOI
  52. Mrabti, 2022, Medicinal Uses, Phytochemistry, Pharmacology, and Toxicology of Mentha spicata, Evid.-Based Complement. Altern. Med., 2022, 7990508
  53. Mahendran, 2021, The traditional uses, phytochemistry and pharmacology of spearmint (Mentha spicata L.): A review, J. Ethnopharmacol., 278, 114266, 10.1016/j.jep.2021.114266 · DOI
  54. Saqib, S., Ullah, F., Naeem, M., Younas, M., Ayaz, A., Ali, S., and Zaman, W. (2022). Mentha: Nutritional and Health Attributes to Treat Various Ailments Including Cardiovascular Diseases. Molecules, 27. · DOI
  55. Petrisor, G., Motelica, L., Craciun, L.N., Oprea, O.C., Ficai, D., and Ficai, A. (2022). Melissa officinalis: Composition, Pharmacological Effects and Derived Release Systems—A Review. Int. J. Mol. Sci., 23. · DOI
  56. Stoyanova, N., Spasova, M., Manolova, N., Rashkov, I., Kamenova-Nacheva, M., Staleva, P., and Tavlinova-Kirilova, M. (2023). Electrospun PLA-Based Biomaterials Loaded with Melissa officinalis Extract with Strong Antioxidant Activity. Polymers, 15. · DOI
  57. Ghazizadeh, 2020, Melissa officinalis L. hydro-alcoholic extract inhibits anxiety and depression through prevention of central oxidative stress and apoptosis, Exp. Physiol., 105, 707, 10.1113/EP088254 · DOI
  58. Miraj, 2017, Melissa officinalis L: A Review Study With an Antioxidant Prospective, Evid. Based Complement. Alternat Med., 22, 385, 10.1177/2156587216663433 · DOI
  59. Swor, K., Poudel, A., Satyal, P., and Setzer, W.N. (2024). The Essential Oil Compositions of Ambrosia acanthicarpa Hook., Artemisia ludoviciana Nutt., and Gutierrezia sarothrae (Pursh) Britton & Rusby (Asteraceae) from the Owyhee Mountains of Idaho. Molecules, 29. · DOI
  60. Kamarauskaite, J., Baniene, R., Raudone, L., Vilkickyte, G., Vainoriene, R., Motiekaityte, V., and Trumbeckaite, S. (2021). Antioxidant and mitochondria-targeted activity of caffeoylquinic-acid-rich fractions of wormwood (Artemisia absinthium L.) and silver wormwood (Artemisia ludoviciana Nutt.). Antioxidants, 10. · DOI
  61. Palacios-Espinosa, J.F., Núñez-Aragón, P.N., Gomez-Chang, E., Linares, E., Bye, R., and Romero, I. (2021). Anti-Helicobacter pylori Activity of Artemisia ludoviciana subsp. mexicana and Two of Its Bioactive Components, Estafiatin and Eupatilin. Molecules, 26. · DOI
  62. 2020, Efficacy of purified fractions of Artemisia ludoviciana Nutt. mexicana and ultraestructural damage to newly excysted juveniles of Fasciola hepatica in vitro, Vet. Parasitol., 285, 109184, 10.1016/j.vetpar.2020.109184 · DOI
  63. Mata, 2017, Quantitative Analysis and Pharmacological Effects of Artemisia ludoviciana Aqueous Extract and Compounds, Nat. Prod. Commun., 12, 1531
  64. Genisheva, 2019, In vitro gastrointestinal digestion of microencapsulated extracts of Flourensia cernua, F. microphylla, and F. retinophylla, Ind. Crops Prod., 138, 111444, 10.1016/j.indcrop.2019.06.007 · DOI
  65. 2017, Antifungal activity in vitro of ethanol and aqueous extracts of leaves and branches of Flourensia spp. against postharvest fungi, Ind. Crops Prod., 107, 499, 10.1016/j.indcrop.2017.04.054 · DOI
  66. Rojas, 2020, Valorization of Flourensia cernua DC as source of antioxidants and antifungal bioactives, Ind. Crops Prod., 152, 112422, 10.1016/j.indcrop.2020.112422 · DOI
  67. Assanga, 2020, Comparative analysis of phenolic content and antioxidant power between parasitic Phoradendron californicum (toji) and their hosts from Sonoran Desert, Results Chem., 2, 100079, 10.1016/j.rechem.2020.100079 · DOI
  68. Iloki-Assanga, S.B., Lewis-Luján, L.M., Lara-Espinoza, C.L., Gil-Salido, A.A., Fernandez-Angulo, D., Rubio-Pino, J.L., and Haines, D.D. (2015). Solvent effects on phytochemical constituent profiles and antioxidant activities, using four different extraction formulations for analysis of Bucida buceras L. and Phoradendron californicum Complementary and Alternative Medicine. BMC Res. Notes, 8. · DOI · Paper page
  69. Mathiasen, 2016, The classification of California Viscaceae: An alternative perspective, Madroño, 63, 8, 10.3120/0024-9637-63.1.8 · DOI
  70. Martínez-Ávila, G.C.G., Aguilar-Zarate, P., and Rojas, R. (2021). Currently Applied Extraction Processes for Secondary Metabolites from Lippia turbinata and Turnera diffusa and Future Perspectives. Separations, 8. · DOI
  71. Chaurasiya, N.D., Zhao, J., Pandey, P., Doerksen, R.J., Muhammad, I., and Tekwani, B.L. (2019). Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from Turnera diffusa (Damiana). Molecules, 24. · DOI
  72. Tousson, E., Hafez, E., Zaki, S., Gad, A., and Elgharabawy, R.M. (2020). Evaluation of the testicular protection conferred by damiana (Turnera diffusa Willd.) against amitriptyline-induced testicular toxicity, DNA damage and apoptosis in rats. Biomed. Pharmacother., 132. · DOI
  73. Szewczyk, 2014, Ethnobotany, phytochemistry, and bioactivity of the genus Turnera (Passifloraceae) with a focus on damiana—Turnera diffusa, J. Ethnopharmacol., 152, 424, 10.1016/j.jep.2014.01.019 · DOI
  74. 2017, Natural variability of essential oil and antioxidants in the medicinal plant Turnera diffusa, Asian Pac. J. Trop. Med., 10, 121, 10.1016/j.apjtm.2017.01.013 · DOI
  75. Yuan, H., Ma, Q., Ye, L., and Piao, G. (2016). The Traditional Medicine and Modern Medicine from Natural Products. Molecules, 21. · DOI
  76. Feng, W., Ao, H., and Peng, C. (2018). Gut microbiota, short-chain fatty acids, and herbal medicines. Front. Pharmacol., 9. · DOI · Paper page
  77. An, X., Bao, Q., Di, S., Zhao, Y., Zhao, S., Zhang, H., Lian, F., and Tong, X. (2019). The interaction between the gut Microbiota and herbal medicines. Biomed. Pharmacother., 118. · DOI
  78. Gasaly, 2020, Fitoquímicos: Una nueva clase de prebióticos, Rev. Chil. Nutr., 47, 317, 10.4067/S0717-75182020000200317 · DOI
  79. Builders, P.F. (2019). Plants Secondary Metabolites: The Key Drivers of the Pharmacological Actions of Medicinal Plants. Herbal Medicine, IntechOpen. · DOI
  80. Kanwal, 2020, Oleandrin: A bioactive phytochemical and potential cancer killer via multiple cellular signaling pathways, Food Chem. Toxicol., 143, 111570, 10.1016/j.fct.2020.111570 · DOI
  81. Kandsi, F., Conte, R., Marghich, M., Lafdil, F.Z., Alajmi, M.F., Bouhrim, M., Mechchate, H., Hano, C., Aziz, M., and Gseyra, N. (2021). Phytochemical Analysis, Antispasmodic, Myorelaxant, and Antioxidant Effect of Dysphania ambrosioides (L.) Mosyakin and Clemants Flower Hydroethanolic Extracts and Its Chloroform and Ethyl Acetate Fractions. Molecules, 26. · DOI
  82. Hernández-Marín, D.A., Castro-Rios, R., Chávez-Montes, A., Castillo-Hernández, S.L., Elizondo-Luevano, J.H., Muñoz-Ortega, M.H., and Sánchez-García, E. (2024). Antiparasitic Activity of Isolated Fractions from Parthenium incanum Kunth against the Hemoflagellate Protozoan Trypanosoma cruzi. Antibiotics, 13. · DOI
  83. Jedidi, 2021, Strong protective effects of Salvia officinalis L. leaves decoction extract against acetic acid-induced ulcerative colitis and metabolic disorders in rat, J. Funct. Foods, 79, 104406, 10.1016/j.jff.2021.104406 · DOI
  84. Bouyahya, 2021, Traditional use, phytochemistry, toxicology, and pharmacology of Origanum majorana L., J. Ethnopharmacol., 265, 113318, 10.1016/j.jep.2020.113318 · DOI
  85. Khadhri, 2017, In vitro digestion, antioxidant and antiacetylcholinesterase activities of two species of Ruta: Ruta chalepensis and Ruta montana, Pharm. Biol., 55, 101, 10.1080/13880209.2016.1230634 · DOI
  86. 2022, Perfil fitoquímico, actividad antimicrobiana y antioxidante de extractos de Gnaphalium oxyphyllum y Euphorbia maculata nativas de Sonora, Rev. Mex. Cienc. Pecu., 13, 928, 10.22319/rmcp.v13i4.6042 · DOI
  87. Salehi, B., Valussi, M., Flaviana Bezerra Morais-Braga, M., Nalyda Pereira Carneiro, J., Linkoln Alves Borges Leal, A., Douglas Melo Coutinho, H., Vitalini, S., Kręgiel, D., Antolak, H., and Sharifi-Rad, M. (2018). Tagetes spp. Essential Oils and Other Extracts: Chemical Characterization and Biological Activity. Molecules, 23. · DOI
  88. Lombrea, A., Antal, D., Ardelean, F., Avram, S., Pavel, I.Z., Vlaia, L., Mut, A.M., Diaconeasa, Z., Dehelean, C.A., and Soica, C. (2020). A Recent Insight Regarding the Phytochemistry and Bioactivity of Origanum vulgare L.. Essential Oil. Int. J. Mol. Sci., 21. · DOI
  89. Purushothaman, 2018, A Comprehensive Review on Ocimum basilicum, J. Nat. Remedies., 18, 71, 10.18311/jnr/2018/21324 · DOI
  90. Satyal, P., Jones, T.H., Lopez, E.M., McFeeters, R.L., Ali, N.A.A., Mansi, I., Al-Kaf, A.G., and Setzer, W.N. (2017). Chemotypic Characterization and Biological Activity of Rosmarinus officinalis. Foods, 6. · DOI
  91. Rashid, H.M., Mahmod, A.I., Afifi, F.U., and Talib, W.H. (2022). Antioxidant and Antiproliferation Activities of Lemon Verbena (Aloysia citrodora): An In Vitro and In Vivo Study. Plants, 11. · DOI
  92. Oladeji, 2019, Phytochemistry and pharmacological activities of Cymbopogon citratus: A review, Sci. Afr., 6, e00137
  93. Batiha, G.E.S., Olatunde, A., El-mleeh, A., Hetta, H.F., Al-rejaie, S., Alghamdi, S., Zahoor, M., Beshbishy, A.M., Murata, T., and Zaragoza-bastida, A. (2020). Bioactive Compounds, Pharmacological Actions, and Pharmacokinetics of Wormwood (Artemisia absinthium). Antibiotics, 9. · DOI
  94. Wang, 2020, Advances and challenges in medicinal plant breeding, Plant Sci., 298, 110573, 10.1016/j.plantsci.2020.110573 · DOI
  95. 2020, Importance of ethnopharmacological studies in drug discovery: Role of medicinal plants, Phytochem. Rev., 19, 1199, 10.1007/s11101-019-09629-9 · DOI
  96. Joshi, 2017, The Ayurvedic Pharmacopoeia of India, development and perspectives, J. Ethnopharmacol., 197, 32, 10.1016/j.jep.2016.07.030 · DOI
  97. 2014, Las Farmacopeas Mexicanas en la construcción de la identidad nacional, Rev. Mex. Cienc. Farm., 45, 43
  98. Iannitti, 2016, Effectiveness and Safety of Arnica Montana in Post-Surgical Setting, Pain and Inflammation, Am. J. Ther., 23, e184, 10.1097/MJT.0000000000000036 · DOI
  99. Sotiropoulou, N.S., Megremi, S.F., and Tarantilis, P. (2020). Evaluation of antioxidant activity, toxicity, and phenolic profile of aqueous extracts of chamomile (Matricaria chamomilla L.) and sage (Salvia officinalis L.) prepared at different temperatures. Appl. Sci., 10. · DOI
  100. Yang, 2021, Fumigant toxicity and physiological effects of spearmint (Mentha spicata, Lamiaceae) essential oil and its major constituents against Reticulitermes dabieshanensis, Ind Crop Prod., 171, 113894, 10.1016/j.indcrop.2021.113894 · DOI
  101. 2019, Toxic essential oils, part VI: Acute oral toxicity of lemon balm (Melissa officinalis L.) essential oil in BALB/c mice, Food Chem. Toxicol., 113, 110794
  102. Burgoa, 2022, Antimycobacterial, cytotoxic, and anti-inflammatory activities of Artemisia ludoviciana, J. Ethnopharmacol., 293, 115249, 10.1016/j.jep.2022.115249 · DOI
  103. Jasso de Rodríguez, D., Torres-Moreno, H., López-Romero, J.C., Vidal-Gutiérrez, M., Villarreal-Quintanilla, J.A., Carrillo-Lomelí, D.A., Robles-Zepeda, R.E., and Vilegas, W. (2023). Antioxidant, Anti-Inflammatory, and Antiproliferative Activities of Flourensia spp.. Biocatal. Agric. Biotechnol., 47. · DOI
  104. Leyva, 2024, Actividad Antioxidante, Antiproliferativa y Antibacteriana de Extractos de Phoradendron californicum; una Planta Parásita del Noroeste de México, Biotecnia, 26, 401, 10.18633/biotecnia.v26.2286 · DOI
  105. Jebur, 2019, Modulatory effect of Turnera diffusa against testicular toxicity induced by fenitrothion and/or hexavalent chromium in rats, Environ. Toxicol., 34, 330, 10.1002/tox.22688 · DOI

Cited by

Metadata

Authors
Julián-Flores, A., Aguilar-Zárate, P., Michel, M. R., Sepúlveda-Torre, L., Torres-León, C., Aguilar, C. N., & Chávez-González, M. L.
Venue
Plants
Publisher
MDPI AG
Published
2025-02-20
Volume
14
Issue
5
Pages
642
ISSN
2223-7747
Cited by
17
References
8
Language
en
Funders
Tecnológico Nacional de México (20024.24-P)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.